These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37120511)

  • 1. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis.
    She Y; Xu X; Yu Q; Yang X; He J; Tang XX
    Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation.
    Sandahl M; Hunter DM; Strunk KE; Earp HS; Cook RS
    BMC Dev Biol; 2010 Dec; 10():122. PubMed ID: 21192804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.
    Chen R; Huang B; Lian M; Wei Y; Miao Q; Liang J; Ou Y; Liang X; Zhang H; Li Y; Xiao X; Wang Q; You Z; Chai J; Gershwin ME; Tang R; Ma X
    J Hepatol; 2023 Dec; 79(6):1478-1490. PubMed ID: 37659731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
    Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl.
    Guimarães-Pinto K; Leandro M; Corrêa A; Maia EP; Rodrigues L; da Costa ALA; Rafael Machado Ferreira J; Claudio-Etienne E; Siebenlist U; He J; Rigoni TDS; Ferreira TPT; Jannini-Sa YAP; Matos-Guedes HL; Costa-da-Silva AC; Lopes MF; Silva PMR; Kelsall BL; Filardy AA
    Front Immunol; 2024; 15():1380628. PubMed ID: 38774866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Corpse Clearance after Lung Damage: The Essential Role of MerTK-mediated Alveolar Macrophage Efferocytosis.
    Haczku A
    Am J Respir Cell Mol Biol; 2024 Jun; 70(6):433-434. PubMed ID: 38502903
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
    Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
    Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
    Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
    Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
    Nishi C; Yanagihashi Y; Segawa K; Nagata S
    J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
    Bae SH; Kim JH; Park TH; Lee K; Lee BI; Jang H
    Exp Mol Med; 2022 Sep; 54(9):1450-1460. PubMed ID: 36056187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages.
    Wanke F; Gutbier S; Rümmelin A; Steinberg M; Hughes LD; Koenen M; Komuczki J; Regan-Komito D; Wagage S; Hesselmann J; Thoma R; Brugger D; Christopeit T; Wang H; Point F; Hallet R; Ghosh S; Rothlin CV; Patsch C; Geering B
    Cell Death Dis; 2021 May; 12(6):538. PubMed ID: 34035216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PM
    Liang S; Sun Q; Du Z; Ren X; Xu Q; Sun Z; Duan J
    Nanotoxicology; 2022 Apr; 16(3):290-309. PubMed ID: 35653618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury.
    Soliman E; Leonard J; Basso EKG; Gershenson I; Ju J; Mills J; de Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH
    J Neuroinflammation; 2023 Nov; 20(1):256. PubMed ID: 37941008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
    Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB
    J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease.
    Soldano S; Smith V; Montagna P; Gotelli E; Campitiello R; Pizzorni C; Paolino S; Sulli A; Cere A; Cutolo M
    Arthritis Res Ther; 2024 Mar; 26(1):74. PubMed ID: 38509595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
    Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
    Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential polarization and the expression of efferocytosis receptor MerTK on M1 and M2 macrophages isolated from coronary artery disease patients.
    Mohd Idrus FN; Ahmad NS; Hoe CH; Azlan M; Norfuad FA; Yusof Z; Wan Isa WYH; Mohamed Ali AA; Yvonne-Tee GB
    BMC Immunol; 2021 Mar; 22(1):21. PubMed ID: 33761885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-Resident Alveolar Macrophages Reduce Ozone-induced Inflammation via MerTK-mediated Efferocytosis.
    Guttenberg MA; Vose AT; Birukova A; Lewars K; Cumming RI; Albright MC; Mark JI; Salazar CJ; Swaminathan S; Yu Z; Sokolenko YV; Bunyan E; Yaeger MJ; Fessler MB; Que LG; Gowdy KM; Misharin AV; Tighe RM
    Am J Respir Cell Mol Biol; 2024 Jun; 70(6):493-506. PubMed ID: 38386777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Enhanced MerTK-Dependent Macrophage Efferocytosis by Extracellular Vesicles.
    de Couto G; Jaghatspanyan E; DeBerge M; Liu W; Luther K; Wang Y; Tang J; Thorp EB; Marbán E
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2082-2096. PubMed ID: 31434491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis.
    Wu J; Liu S; Banerjee O; Shi H; Xue B; Ding Z
    Theranostics; 2024; 14(6):2427-2441. PubMed ID: 38646649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.